SecBot SecBot
8-K ·Filed Nov 5, 2026

KPTI

Karyopharm Therapeutics Inc.
BEARISH
Impact 8/10
Horizonimmediate Processed11d 19h ago SEC0001193125-26-448516
8-K context-dependent: Items 3.01
Actionable Insight ▼ Bearish

The stock will move to OTC trading with symbol KPTIQ starting November 11, but the Chapter 11 plan indicates zero recovery for equity holders. Monitor bankruptcy court proceedings for any plan amendments or asset sale outcomes that could alter recovery prospects.

DirectionBearish
Confidencehigh
Horizonimmediate

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+5
Entry
$0.0601
T+0 close · Nov 5, 2026 · via day close
Latest settled
−71.05%
T+5 · $0.0174 · next T+20 in 17d
Vs SPY
−74.34%
α at T+5
Latest observation
−55.39%
T+6 · FF3 residual α
  1. T+0 · Nov 5 $0.0601entry
  2. T+1 · 11d ago −8.65%α −8.96% · $0.0549
  3. T+5 · 5d ago −71.05%α −74.34% · $0.0174
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Karyopharm Therapeutics received a delisting notice from Nasdaq following its Chapter 11 bankruptcy filing on November 2, 2026. Nasdaq determined to delist the company's common stock based on public interest concerns, residual equity concerns, and compliance issues. The company will not appeal, trading will be suspended on Nasdaq at the open on November 11, 2026, and the stock is expected to move to OTC under symbol KPTIQ. The company's prepackaged Chapter 11 plan provides that holders of common stock and preferred stock will receive no distribution, implying a complete loss of equity value.

Key Facts

  • Company filed Chapter 11 bankruptcy petitions on November 2, 2026
  • Nasdaq notified company on November 4, 2026 of delisting determination under Listing Rules 5101, 5110(b) and IM-5101-1
  • Company will not appeal the delisting determination
  • Trading suspension on Nasdaq at the opening of business on November 11, 2026
  • Form 25-NSE will be filed to remove securities from listing and registration
  • Common stock expected to trade on OTC market under symbol KPTIQ on or after November 11, 2026
  • Joint Prepackaged Chapter 11 Plan provides that holders of common stock and 0% Series A Convertible Perpetual Preferred Stock will receive no payment or distribution
  • Company states existing equity securities will have no value and holders will experience a complete loss

Financial Impact

Complete loss of equity value for common and preferred stockholders per the Chapter 11 plan; market cap of $2M as of analysis time

equity valuelisting status

Risk Factors

  • OTC market may not develop or be maintained for the stock
  • Chapter 11 plan provides for zero recovery to equity holders, implying complete loss
  • Trading during bankruptcy is highly speculative per company's own cautionary statement

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (11 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-448516
Document: 0001193125-26-448516-index-headers.html0001193125-26-448516
Document: 0001193125-26-448516-index.html0001193125-26-448516
Document: 0001193125-26-448516.txt0001193125-26-448516

Track record

30 reports on KPTI

Performance horizon

5 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +97.24% at T+60 after the Aug 13, 2026 report. 12 of 13 went positive at some point.

Filters
  1. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $0.0102 Now $0.0290 +184.31% settles Feb 12
  2. Nov 13, 20263d ago NT 10-Q Bearish 7/10 Entry $0.0102 Now $0.0290 −184.31% settles Feb 12
  3. Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $0.0260 Now $0.0290 +11.54% settles Feb 10
  4. Nov 9, 20267d ago SC 13G/A Neutral 2/10 Entry $0.0400 Now $0.0290 −27.50% settles Feb 5
  5. Nov 5, 202611d ago 8-K Bearish 8/10 Viewing Entry $0.0601 Now $0.0290 +51.75% settles Feb 3
  6. Nov 2, 202614d ago 8-K Bearish 10/10 Entry $0.0883 Now $0.0290 +67.16% settles Feb 1
  7. Nov 2, 202614d ago 8-K Bearish 7/10 Entry $0.1120 Now $0.0290 +74.11% settles Jan 29
  8. Oct 28, 202619d ago SC 13G/A Bearish 5/10 Entry $0.8798 Now $0.0290 +96.70% settles Jan 27
  9. Oct 22, 202625d ago 8-K Bearish 6/10 Entry $0.5175 Now $0.0290 +94.40% settles Jan 21
  10. Oct 14, 20264w ago 8-K Neutral 3/10 Entry $0.3150 Now $0.0290 −90.79% settles Jan 11
Showing 10 of 30

US Market Status

Market Closed · Opens in 6h 58m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026